0
Sign In  | Subscribe
16 September 2003, Vol 139, No. 6>
Summaries for Patients | 16 September 2003

Effects of Antibiotic Treatment for Helicobacter pylori on Normal Bowel Bacteria FREE

[+] Article and Author Information

The summary below is from the full report titled “Long-Term Persistence of Resistant Enterococcus Species after Antibiotics To Eradicate Helicobacter pyori.” It is in the 16 September 2003 issue of Annals of Internal Medicine (volume 139, pages 483-487). The authors are M. Sjölund, K. Wreiber, D.I. Andersson, M.J. Blaser, and L. Engstrand.


Ann Intern Med. 2003;139(6):I-42. doi:10.7326/0003-4819-139-6-200309160-00004
Text Size: A A A

What is the problem and what is known about it so far?

Dyspepsia is stomach pain or discomfort. It may occur in patients with sores in the stomach lining (ulcers) or in patients who do not have ulcers. Sometimes tests show that patients with dyspepsia or ulcers have a common bacterial infection known as Helicobacter pylori infection. A combination of drugs that treat infection (antibiotics) and drugs that block stomach acid is widely used to treat H. pylori infections. The antibiotics usually rid the body of the H. pylori infection within 2 weeks. However, they also could affect other bacteria in the body. For example, bacteria sometimes develop an ability to thwart the action of antibiotics (resistance). Bacteria that are normally found in the body can develop resistance to antibiotics, even if the antibiotics are given to fight different bacteria that cause infection. This might cause problems later if a patient gets an infection with bacteria similar to those normally found in the body.

Why did the researchers do this particular study?

To learn whether a combination of drugs (clarithromycin, metronidazole, and omeprazole) widely used to kill H. pylori affects antibiotic resistance of a normal species of bacteria (Enterococcus) in the colon.

Who was studied?

10 patients who had endoscopy to evaluate dyspepsia.

How was the study done?

Doctors treated 5 of the patients, who had ulcers and H. pylori infection, with antibiotics (clarithromycin and metronidazole). They did not give the 5 patients without ulcers antibiotics. The researchers collected fecal samples from all patients at the beginning of the study and then several days and 1 and 3 years later. They cultured enterococci from the samples and did special tests (DNA fingerprints, gene tests, and minimal inhibitory concentration) to see whether the enterococci were resistant to clarithromycin.

What did the researchers find?

All enterococci that were found in feces several days after treatment with antibiotics were highly resistant to clarithromycin. In 3 of the treated patients, resistance persisted for 1 to 3 years. No enterococci in untreated patients were resistant to clarithromycin.

What were the limitations of the study?

The number of patients was small. The long-term implications of having enterococci in the colon that were resistant to commonly used antibiotics were not studied.

What are the implications of the study?

Short-term treatment of H. pylori infection with a commonly used antibiotic leaves behind bacteria in the colon that are resistant to that antibiotic. Whether and how this resistance will eventually lead to clinical problems is not yet clear.

Figures

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Compression-Only CPR: Pushing the Science Forward
Cone
AAM 2010;304:1493-1495.
All you need to read in the other general jounals
BMJ 2010;341:c5893-c1494.

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Buy This Article

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Register Now for a free account
Advertisement

Related Content

Customize your page view by dragging & repositioning the boxes below.

In the Clinic
Community-Acquired Pneumonia
Ann Intern Med. 2009;151(7):ITC4-1.
Topic Collections
PubMed Articles
Predictive factors for improvement of atrophic gastritis and intestinal metaplasia after Helicobacter pylori eradication: a three-year follow-up study in Korea.
Helicobacter Issue date: 2012 Apr
H. pylori eradication did not improve dysregulation of specific oncogenic miRNAs in intestinal metaplastic glands.
Journal of gastroenterology Issue date: 2012 Sep

Annals of Internal Medicine

Other Resources

Copyright © 2013 The American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704

Buy This Article

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Register Now for a free account
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)